Artigo Acesso aberto Revisado por pares

Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

2022; Elsevier BV; Volume: 34; Issue: 1 Linguagem: Inglês

10.1016/j.annonc.2022.10.003

ISSN

1569-8041

Autores

Andrés Cervantes, R. Adam, Susana Roselló, Dirk Arnold, Nicola Normanno, Julien Taı̈eb, Jenny F. Seligmann, Thierry de Baère, Pia Österlund, Takayuki Yoshino, Erika Martinelli,

Tópico(s)

Colorectal Cancer Surgical Treatments

Resumo

Colorectal cancer (CRC) is the third most common cancer worldwide, with 1.1 million new cases per year, and is the second leading cause of cancer death.1 CRC occurs more frequently in middle- to high-income countries with an eightfold variation in incidence across the world. This rise may be associated with known risk factors, including alcohol intake, tobacco use, obesity, sedentariness and dietary patterns (diets low in fruits, vegetables and unrefined plant food, and high in red meat, processed foods and fat).

Referência(s)
Altmetric
PlumX